DSS30
DSS30 is a P25/CDK5 inhibitor that reduces β-amyloid (Aβ) secretion by inhibiting amyloid precursor protein lyase 1 (BACEl) phosphorylation. DSS30 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 883027-32-5
- Formule: C16H14ClNO3S2
- Masse moléculaire:367.87
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
DSS30 (50 μM, 2 hours) inhibits the activity of the P25/CDK5 complex by up to 50% and the phosphorylation of BACE1 or Tau[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Expressed P25 PC12tet-off cell lines
-
Concentration:50 μM
-
Incubation Time:8 hours
-
Result:Inhibited BACE1 phosphorylation by 12%.
Chemical Information
-
CAS No. 883027-32-5
-
Masse moléculaire 367.87
-
Formule C16H14ClNO3S2
-
SMILES
CC1=C(S(NC2=CC=CC=C2OC)(=O)=O)SC(C=C3)=C1C=C3Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)